-
Study aim
-
Evaluation of direct and alternating electrical stimulation of brain on cognitive functions and symptoms in people with schizophrenia
-
Design
-
A double-blind, randomized clinical trial with a control group on 114 patients. Random allocation software will be used for randomization.
-
Settings and conduct
-
In the first phase, 54 eligible patients with schizophrenia will be randomly assigned into two groups of 27 and in the second phase, another 60 patients will be randomly assigned into three groups of 20. This clinical trial is double-blind and the patient and the outcome assessor are not aware of the type of intervention. The study site will be Fatemi Hospital in Ardabil.
-
Participants/Inclusion and exclusion criteria
-
Inclusion: Diagnosis of schizophrenia based on DSM V, Being 18-50 years old, Required written informed consent signed by patients' guardian, Exclusion: Pregnancy, The existence of metal implants in the body, History of neurological diseases
-
Intervention groups
-
In the first phase, patients will be randomly assigned into two groups. The first group will receive three conditions of tDCS (2 mA, 3 mA, and sham) and the second group will receive three conditions of tACS (8 Hz, 40 Hz, and sham) in three sessions of 20 minutes with an interval of three days. the anodic electrode is placed over the F3 and the cathode electrode is placed over the right shoulder. In the second phase, another 60 patients will be randomly assigned into three groups with active tDCS, active tACS, and sham, and by the results of the first phase, the stimulation will be performed for 10 consecutive days in two sessions of 20 minutes per day, with an interval of 20 minutes. Sham stimulation is as same as active stimulation, except that there will be no current and the device will turn off after one minute.
-
Main outcome variables
-
cognitive functions؛ Symptoms of schizophrenia